Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Seminars in Hematology|July 13, 2001
Clinical evaluation of B-domain deleted recombinant factor VIII in previously untreated patientsS G Courter, C L BedrosianSeminars in Hematology|July 13, 2001
Clinical evaluation of B-domain deleted recombinant factor VIII in previously treated patientsS G Courter, C L BedrosianDevelopments in Biological Standardization|January 1, 1994
A clinical evaluation of genetic stabilityE D Gomperts, S G Courter, M D Lynes, et al.Clinical Therapeutics|January 1, 1987
Safety of an intravenous immunoglobulin preparation: lack of seroconversion for human immunodeficiency virus antibodiesM L Lee, H S Kingdon, J Hooper, et al.Blood|December 12, 2001
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentratesD A Roth, C M Kessler, K J Pasi, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|April 16, 2002
Use of recombinant factor IX in subjects with haemophilia B undergoing surgeryM V Ragni, K J Pasi, G C White, et al.Thrombosis and Haemostasis|February 2, 1992
Treatment of hemophilia A with a highly purified factor VIII concentrate prepared by anti-FVIIIc immunoaffinity chromatographyJ E Addiego, E Gomperts, S L Liu, et al.Pageof 1